SAN JOSE, Calif. –– Thermo Fisher Scientific has announced that The Thermo Scientific Prelude LX-4 MD HPLC has been listed as an FDA Class I medical device for general clinical use. The device features four parallel channels which can deliver up to four different separations to a single mass spectrometer to enhance sample throughput. The channels can run identical or different methods simultaneously.

“We’re strongly committed to bringing the advantages of LC-MS to the clinical market, and this product is part of a larger initiative to make mass spectrometry more useful and accessible to the clinician,” said Dan Shine, president of chromatography and mass spectrometry for Thermo Fisher Scientific.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of $17 billion and 50,000 employees in 50 countries. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through our four premier brands – Thermo Scientific, Life Technologies, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit www.thermofisher.com.